GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

The Forsaken Hollows bring back Mogh, the Lord of Blood, to Elden Ring: Nightreign. Here are some useful tips against him.

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

Share on Pinterest New research suggests that stopping GLP-1 drugs before pregnancy is linked to complications like gestational diabetes and preeclampsia. Tatsiana Volkava/Getty Images A recent study ...

Please provide your email address to receive an email when new articles are posted on . A new WHO guideline states adults with obesity could receive GLP-1 therapy as long-term treatment. The authors ...

The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in ...